VC Investments in Biotech Collapse, Threaten Health Care
The Atlantic | Medical device, biotech and diagnostic companies account for about a third of all angel and venture capital investments. But today, this system is in collapse, jeopardizing the very foundation of what has made the U.S. health care system the envy of the modern world.
September 26, 2011 | Innovation is the jewel in the crown of the U.S. health care system. We surely can't brag about having the most affordable medical insurance, or the longest-living patients. But we can brag, and do brag, about having the most cutting-edge medical- and bio-technology in the world. Medical device, biotech and diagnostic companies account for about a third of all angel and venture capital investments. But today, this system is in collapse, jeopardizing the very foundation of what has made the U.S. healthcare system the envy of the modern world. The Atlantic